Galecto, Inc. - GLTO Company Short-Term Debt

Public company logo of Galecto, Inc. (GLTO)

Galecto, Inc. (GLTO) operations rely on the international transportation of biomaterials under strict temperature controls to preserve drug properties. The firm's environmental footprint is minimal, as the company focuses on clinical trials of molecules. The business is based on the creation of unique galectin-3 inhibitors for the therapy of organ fibrosis, where the indicator is 0.00. This chart illustrating the price evolution of the quotes is presented below.

GLTO (Galecto Inc) Company Short-Term Debts history from 07/04/2022 to 03/10/2026

Summary analytical data breakdowns for Galecto Corporation (GLTO)

- price and consensus price forecast:
Price Chart Galecto|GLTO - Fair Value Consensus
- market capitalization data:
Market Value Galecto, Inc.|GLTO - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Galecto|GLTO - Book Capitalization|Market Cap to Net Assets Ratio galecto.com|GLTO - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Galecto, Inc.|GLTO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Galecto, Inc.|GLTO - Company Cumulative Debt|Debt to Book Value Galecto, Inc.|GLTO - Amount of Long-Term Liabilities|Company Short-Term Debts Galecto
Initial company analysis:GLTO (Galecto)
Flagship merchandise of Galecto Corporation

Professional selection of sustainable assets begins with an analysis of liquidity and the issuer's ability to service obligations with maturities of up to one year. The dynamics of Galecto, Inc. short-term loans and credits reflect the total current debt obligations, which is critical for Galecto, Inc., as its financial stability—amid strict FDA requirements and the protection of its galectin inhibitor patent portfolio—determines the business's margin of safety.

Competitors of Galecto, Inc. (GLTO)

Company Short-Term Debt Ascendis Pharma (ASND)|MDGL: Company Short-Term Loans and Borrowings|CORT (Corcept) - Company Short-Term Debt|Rhythm Corp (RYTM) - Company Current Liabilities|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com (MTSR)|MoonLake (MLTX) - Company Current Liabilities|Company Short-Term Loans and Borrowings CRNX (Crinetics Pharmaceuticals, Inc.)|NewAmsterdam Pharma N.V. - Company Short-Term Debt|Company Current Liabilities Soleno Therapeutics Corp SLNO|FOLD (Amicus Therapeutics) - Company Short-Term Debts|89bio.com (ETNB) - Short-Term Debt|AGIO - Company Current Liabilities|Structure Therapeutics Inc (GPCR) - Amount of Current Liabilities|MDXG (MiMedx Group) - Company Short-Term Debts|Company Short-Term Debts Rezolute Bio|Company Short-Term Debts Lexicon Pharmaceuticals (LXRX)|Company Short-Term Debt MBX (mbxbio.com)|ALT: Company Short-Term Debt|Aardvark Therapeutics Inc. - Short-Term Debt|SGMT - Company Short-Term Debt|BIOA - Company Short-Term Debt|Biomea Fusion, Inc. - Company Short-Term Debts|QNCX (Quince Therapeutics, Inc.) - Short-Term Debt Volume|GUTS: Company Short-Term Debt|Short-Term Debt Volume VTVT|Company Short-Term Debt ATPC (Agape ATP Corporation)|Company Current Liabilities pluri-biotech.com (PLUR)|SYBX (Synlogic) - Company Short-Term Debts|Short-Term Indebtedness lipocine.com LPCN|Matinas BioPharma Holdings Inc. - Company Short-Term Debts|SPRB: Company Short-Term Debts|Carmell Corp (CTCX) - Company Short-Term Debt|Lumos Therapeutics (LUMO) - Company Short-Term Debt|Company Short-Term Debts ONVO (Organovo Holdings, Inc.)|Short-Term Debt radiuspharm.com